CN104874029A - 一种止血防粘连材料及其制备方法 - Google Patents
一种止血防粘连材料及其制备方法 Download PDFInfo
- Publication number
- CN104874029A CN104874029A CN201510143636.6A CN201510143636A CN104874029A CN 104874029 A CN104874029 A CN 104874029A CN 201510143636 A CN201510143636 A CN 201510143636A CN 104874029 A CN104874029 A CN 104874029A
- Authority
- CN
- China
- Prior art keywords
- bleeding stopping
- adherence preventing
- aperture
- sublayer
- preventing material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002439 hemostatic effect Effects 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 239000011345 viscous material Substances 0.000 title abstract 2
- 239000000463 material Substances 0.000 claims abstract description 173
- 230000004913 activation Effects 0.000 claims abstract description 7
- 230000000740 bleeding effect Effects 0.000 claims description 78
- 239000000499 gel Substances 0.000 claims description 34
- 239000000758 substrate Substances 0.000 claims description 30
- 239000002861 polymer material Substances 0.000 claims description 24
- 229920001661 Chitosan Polymers 0.000 claims description 19
- 238000004132 cross linking Methods 0.000 claims description 19
- 239000012190 activator Substances 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 230000023597 hemostasis Effects 0.000 claims description 14
- 159000000007 calcium salts Chemical class 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 12
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 10
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 9
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 8
- 239000002738 chelating agent Substances 0.000 claims description 8
- 239000000835 fiber Substances 0.000 claims description 8
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 8
- 239000004626 polylactic acid Substances 0.000 claims description 8
- 210000000813 small intestine Anatomy 0.000 claims description 8
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 8
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 7
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 7
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 7
- 229940071826 hydroxyethyl cellulose Drugs 0.000 claims description 7
- 210000004400 mucous membrane Anatomy 0.000 claims description 7
- 210000004303 peritoneum Anatomy 0.000 claims description 7
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 7
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 7
- 102000008186 Collagen Human genes 0.000 claims description 6
- 108010035532 Collagen Proteins 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 230000004888 barrier function Effects 0.000 claims description 6
- 229920001436 collagen Polymers 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 6
- 239000004627 regenerated cellulose Substances 0.000 claims description 6
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 4
- 239000000427 antigen Substances 0.000 claims description 4
- 102000036639 antigens Human genes 0.000 claims description 4
- 108091007433 antigens Proteins 0.000 claims description 4
- 239000001110 calcium chloride Substances 0.000 claims description 4
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 4
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 claims description 4
- 229920002101 Chitin Polymers 0.000 claims description 3
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 claims description 3
- 239000004368 Modified starch Substances 0.000 claims description 3
- 229920000881 Modified starch Polymers 0.000 claims description 3
- 229920000954 Polyglycolide Polymers 0.000 claims description 3
- 239000000648 calcium alginate Substances 0.000 claims description 3
- 235000010410 calcium alginate Nutrition 0.000 claims description 3
- 229960002681 calcium alginate Drugs 0.000 claims description 3
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 3
- 150000001718 carbodiimides Chemical class 0.000 claims description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 235000019426 modified starch Nutrition 0.000 claims description 3
- 210000003516 pericardium Anatomy 0.000 claims description 3
- 239000004633 polyglycolic acid Substances 0.000 claims description 3
- DCPMPXBYPZGNDC-UHFFFAOYSA-N hydron;methanediimine;chloride Chemical compound Cl.N=C=N DCPMPXBYPZGNDC-UHFFFAOYSA-N 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 13
- 238000004108 freeze drying Methods 0.000 abstract description 5
- 238000010668 complexation reaction Methods 0.000 abstract description 2
- 238000007605 air drying Methods 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 93
- 208000032843 Hemorrhage Diseases 0.000 description 72
- 239000000243 solution Substances 0.000 description 49
- 238000012360 testing method Methods 0.000 description 38
- 239000010408 film Substances 0.000 description 24
- 206010052428 Wound Diseases 0.000 description 14
- 208000027418 Wounds and injury Diseases 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 230000015556 catabolic process Effects 0.000 description 9
- 238000006731 degradation reaction Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 238000001179 sorption measurement Methods 0.000 description 8
- 206010000050 Abdominal adhesions Diseases 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical group Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000005266 casting Methods 0.000 description 6
- 238000004049 embossing Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 230000000025 haemostatic effect Effects 0.000 description 5
- 230000002980 postoperative effect Effects 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 description 4
- 208000031737 Tissue Adhesions Diseases 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 229940010747 sodium hyaluronate Drugs 0.000 description 4
- 229910021642 ultra pure water Inorganic materials 0.000 description 4
- 239000012498 ultrapure water Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- 231100000899 acute systemic toxicity Toxicity 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 241000283977 Oryctolagus Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 2
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 2
- 229940045110 chitosan Drugs 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000003176 fibrotic effect Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 210000000713 mesentery Anatomy 0.000 description 2
- FEKRFYZGYUTGRY-UHFFFAOYSA-N n'-ethylmethanediimine Chemical compound CCN=C=N FEKRFYZGYUTGRY-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 241000252983 Caecum Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000005422 Foreign-Body reaction Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001582888 Lobus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000031650 Surgical Wound Infection Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000003815 abdominal wall Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- 230000001772 anti-angiogenic effect Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004534 cecum Anatomy 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
材料 | 出血量(g) | 止血时间(秒) |
止血防粘连材料 | 0.12±0.3 | 72.2±0.2 |
壳聚糖止血海绵 | 0.46±0.3 | 140.3±0.2 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510143636.6A CN104874029B (zh) | 2015-03-30 | 2015-03-30 | 一种止血防粘连材料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510143636.6A CN104874029B (zh) | 2015-03-30 | 2015-03-30 | 一种止血防粘连材料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104874029A true CN104874029A (zh) | 2015-09-02 |
CN104874029B CN104874029B (zh) | 2018-04-27 |
Family
ID=53941872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510143636.6A Active CN104874029B (zh) | 2015-03-30 | 2015-03-30 | 一种止血防粘连材料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104874029B (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105194740A (zh) * | 2015-09-20 | 2015-12-30 | 哈尔滨工业大学 | 一种术后防粘连水凝胶及其制备方法 |
CN105287106A (zh) * | 2015-11-03 | 2016-02-03 | 中国人民解放军第四军医大学 | 一种肢体战伤急救专用包扎敷料 |
CN105749358A (zh) * | 2016-02-25 | 2016-07-13 | 哈尔滨工业大学 | 一种复合术后防粘连材料及其制备方法 |
CN106420109A (zh) * | 2016-11-14 | 2017-02-22 | 陕西佰傲再生医学有限公司 | 复合型多孔交联乳房补片及其制备方法 |
CN106983918A (zh) * | 2017-03-03 | 2017-07-28 | 北京博辉瑞进生物科技有限公司 | 一种生物防粘连材料、制备方法及其应用 |
CN107693213A (zh) * | 2017-11-06 | 2018-02-16 | 侯强 | 一种用于创面负压治疗的可降解敷料 |
WO2018082092A1 (en) * | 2016-11-07 | 2018-05-11 | Gunze Limited | Biological tissue-reinforcing material |
CN109394289A (zh) * | 2018-11-30 | 2019-03-01 | 屈小丰 | 一种腔道压迫填塞装置 |
CN110680520A (zh) * | 2019-10-25 | 2020-01-14 | 无锡市儿童医院 | 一种儿童肠道吻合术防粘连辅助操作台 |
CN112121238A (zh) * | 2020-03-18 | 2020-12-25 | 武汉大学 | 一种多功能复合抗粘连材料及其制备方法 |
CN112138204A (zh) * | 2019-06-26 | 2020-12-29 | 广东博与再生医学有限公司 | 骨止血材料 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1887365A (zh) * | 2006-08-01 | 2007-01-03 | 四川大学 | 具有多孔结构的生物材料膜及其制备方法 |
US20070021703A1 (en) * | 2002-06-14 | 2007-01-25 | Hemcon, Inc. | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as chitosan |
US20070161109A1 (en) * | 2006-01-12 | 2007-07-12 | Integra Lifesciences Corporation | Suturable dural and meningeal repair product comprising collagen matrix |
CN201333128Y (zh) * | 2008-12-23 | 2009-10-28 | 上海海洋大学 | 一种保健型创口贴 |
CN101594887A (zh) * | 2005-07-13 | 2009-12-02 | 赫姆孔公司 | 使用由诸如壳聚糖的亲水聚合物泡沫形成的止血剂微粒的止血成分、组件、系统和方法 |
CN102973985A (zh) * | 2012-12-26 | 2013-03-20 | 东华大学 | 一种具备疏密结构的多孔细菌纤维素皮肤修复材料及其制备方法 |
CN103083112A (zh) * | 2012-12-26 | 2013-05-08 | 东华大学 | 一种具备疏密结构的细菌纤维素皮肤修复材料及其制备方法 |
CN103191085A (zh) * | 2012-01-09 | 2013-07-10 | 深圳兰度生物材料有限公司 | 一种双层复合再生膜及其制备方法 |
-
2015
- 2015-03-30 CN CN201510143636.6A patent/CN104874029B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070021703A1 (en) * | 2002-06-14 | 2007-01-25 | Hemcon, Inc. | Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as chitosan |
CN101594887A (zh) * | 2005-07-13 | 2009-12-02 | 赫姆孔公司 | 使用由诸如壳聚糖的亲水聚合物泡沫形成的止血剂微粒的止血成分、组件、系统和方法 |
US20070161109A1 (en) * | 2006-01-12 | 2007-07-12 | Integra Lifesciences Corporation | Suturable dural and meningeal repair product comprising collagen matrix |
CN1887365A (zh) * | 2006-08-01 | 2007-01-03 | 四川大学 | 具有多孔结构的生物材料膜及其制备方法 |
CN201333128Y (zh) * | 2008-12-23 | 2009-10-28 | 上海海洋大学 | 一种保健型创口贴 |
CN103191085A (zh) * | 2012-01-09 | 2013-07-10 | 深圳兰度生物材料有限公司 | 一种双层复合再生膜及其制备方法 |
CN102973985A (zh) * | 2012-12-26 | 2013-03-20 | 东华大学 | 一种具备疏密结构的多孔细菌纤维素皮肤修复材料及其制备方法 |
CN103083112A (zh) * | 2012-12-26 | 2013-05-08 | 东华大学 | 一种具备疏密结构的细菌纤维素皮肤修复材料及其制备方法 |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105194740B (zh) * | 2015-09-20 | 2018-06-26 | 哈尔滨工业大学 | 一种术后防粘连水凝胶及其制备方法 |
CN105194740A (zh) * | 2015-09-20 | 2015-12-30 | 哈尔滨工业大学 | 一种术后防粘连水凝胶及其制备方法 |
CN105287106A (zh) * | 2015-11-03 | 2016-02-03 | 中国人民解放军第四军医大学 | 一种肢体战伤急救专用包扎敷料 |
CN105749358A (zh) * | 2016-02-25 | 2016-07-13 | 哈尔滨工业大学 | 一种复合术后防粘连材料及其制备方法 |
CN109906091B (zh) * | 2016-11-07 | 2021-10-15 | 郡是株式会社 | 生物组织增强材料 |
WO2018082092A1 (en) * | 2016-11-07 | 2018-05-11 | Gunze Limited | Biological tissue-reinforcing material |
CN109906091A (zh) * | 2016-11-07 | 2019-06-18 | 郡是株式会社 | 生物组织增强材料 |
CN106420109A (zh) * | 2016-11-14 | 2017-02-22 | 陕西佰傲再生医学有限公司 | 复合型多孔交联乳房补片及其制备方法 |
CN106983918A (zh) * | 2017-03-03 | 2017-07-28 | 北京博辉瑞进生物科技有限公司 | 一种生物防粘连材料、制备方法及其应用 |
CN106983918B (zh) * | 2017-03-03 | 2020-05-05 | 北京博辉瑞进生物科技有限公司 | 一种生物防粘连材料、制备方法及其应用 |
CN107693213A (zh) * | 2017-11-06 | 2018-02-16 | 侯强 | 一种用于创面负压治疗的可降解敷料 |
CN107693213B (zh) * | 2017-11-06 | 2024-04-30 | 侯强 | 一种用于创面负压治疗的可降解敷料 |
CN109394289A (zh) * | 2018-11-30 | 2019-03-01 | 屈小丰 | 一种腔道压迫填塞装置 |
CN112138204A (zh) * | 2019-06-26 | 2020-12-29 | 广东博与再生医学有限公司 | 骨止血材料 |
CN110680520A (zh) * | 2019-10-25 | 2020-01-14 | 无锡市儿童医院 | 一种儿童肠道吻合术防粘连辅助操作台 |
CN112121238A (zh) * | 2020-03-18 | 2020-12-25 | 武汉大学 | 一种多功能复合抗粘连材料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104874029B (zh) | 2018-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104874029B (zh) | 一种止血防粘连材料及其制备方法 | |
JP6868314B2 (ja) | ヒアルロン酸−カルシウム及びポリリシンを含む創傷被覆材及びその製造方法 | |
Li et al. | Polymer materials for prevention of postoperative adhesion | |
EP3432933B1 (en) | Biocompatible adhesives and methods of use thereof | |
US10195312B2 (en) | Modified starch material of biocompatible hemostasis | |
CN106068133B (zh) | 使用生物聚合物的伤口敷料的制备方法、及利用其方法制备的使用生物聚合物的伤口敷料 | |
EP3199025A1 (en) | Modified starch material of biocompatible hemostasis | |
KR101649792B1 (ko) | 비압박 지혈용 고분자 폼 제조용 조성물, 이를 이용한 비압박 지혈용 고분자 폼의 제조방법 및 비압박 지혈 팩킹용 고분자 폼 | |
JP6962919B2 (ja) | 溶解可能な鼻洞スポンジ | |
JP2008514316A (ja) | 非接着性の弾性ゼラチンマトリックス | |
US20120039959A1 (en) | Anti-Adhesion Alginate Barrier of Variable Absorbance | |
US20210338577A1 (en) | Bio-inspired degradable tough adhesives for diverse wet surfaces | |
JP2009534063A (ja) | 層状創傷包帯 | |
US20220168334A1 (en) | System and method to reduce tissue ororgan adhesion | |
CN102558600A (zh) | 交联透明质酸海绵及其制备方法 | |
Capella-Monsonís et al. | A Comparative Study of the Resorption and Immune Response for Two Starch-Based Hemostat Powders | |
Zawaneh et al. | Materials in surgery: a review of biomaterials in postsurgical tissue adhesion and seroma prevention | |
CN1281816C (zh) | 生物纸 | |
Suzuki et al. | Barriers to Prevent Tissue Adhesion | |
CN109847111B (zh) | 一种包含白及多糖的防粘连材料及其制备方法 | |
Morales-Conde et al. | Prevention and Treatment of Major Complications After Closure of Abdominal Wall and Repair of Abdominal Wall Hernias | |
Scognamiglio | Nano-engineered adhesive biomaterials for biomedical applications | |
CN105363075A (zh) | 一种用于止血和防粘连的可吸收医用材料及其制备方法 | |
Shao et al. | Recent research advances on polysaccharide-, peptide-, and protein-based hemostatic materials: A review | |
Tarusha | Novel nanostructured biomaterials for biomedical applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Hemostatic non-viscous material and preparation method thereof Effective date of registration: 20190410 Granted publication date: 20180427 Pledgee: CITIC Bank Limited by Share Ltd. Xi'an branch Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd.|SHAANXI BIOHONG BIOTECHNOLOGY GROUP CO.,LTD.|GUANGDONG BIOCELL BIOTECHNOLOGY Co.,Ltd. Registration number: 2019610000065 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201020 Granted publication date: 20180427 Pledgee: CITIC Bank Limited by Share Ltd. Xi'an branch Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: 2019610000065 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A hemostatic and anti adhesion material and its preparation method Effective date of registration: 20201106 Granted publication date: 20180427 Pledgee: CITIC Bank Limited by Share Ltd. Xi'an branch Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: Y2020610000198 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230825 Granted publication date: 20180427 Pledgee: CITIC Bank Limited by Share Ltd. Xi'an branch Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: Y2020610000198 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |